GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » YoY EPS Growth

LOBEF (Lobe Sciences) YoY EPS Growth : 100.00% (As of Nov. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Lobe Sciences's YoY EPS Growth for the quarter that ended in Nov. 2024 was 100.00%.

Lobe Sciences's Earnings per Share (Diluted) for the three months ended in Nov. 2024 was $0.00.

Lobe Sciences YoY EPS Growth Historical Data

The historical data trend for Lobe Sciences's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences YoY EPS Growth Chart

Lobe Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -404.44 82.38 -520.00 85.08 21.62

Lobe Sciences Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.18 - - -15.38 100.00

Lobe Sciences YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Lobe Sciences's YoY EPS Growth for the fiscal year that ended in Aug. 2024 is calculated as:

YoY EPS Growth (A: Aug. 2024 )
=(Earnings per Share (Diluted) (A: Aug. 2024 )-Earnings per Share (Diluted) (A: Aug. 2023 ))/ | Earnings per Share (Diluted) (A: Aug. 2023 ) |
=(-0.029--0.037)/ | -0.037 |
=21.62 %

Lobe Sciences's YoY EPS Growth for the quarter that ended in Nov. 2024 is calculated as:

YoY EPS Growth (Q: Nov. 2024 )
=(Earnings per Share (Diluted) (Q: Nov. 2024 )-Earnings per Share (Diluted) (Q: Nov. 2023 )) / | Earnings per Share (Diluted) (Q: Nov. 2023 )) |
=(0--0.007)/ | -0.007 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » YoY EPS Growth
Comparable Companies
TSXV:XRTX XCNQ:ASEP TSXV:IOT TSXV:RKV TSXV:MRVL TSX:APS TSXV:IBO TSX:APLI XCNQ:NURL XCNQ:MYND VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
LOBE:Canada
Address
1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Website
https://www.lobesciences.com
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.